dockets: CMS-2025-0054

Regulatory dockets from Regulations.gov — containers for related documents and comments in a rulemaking proceeding.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id title docket_type last_modified object_id rin dkabstract category subtype keywords program short_title effective_date organization attrs_raw attr_source
CMS-2025-0054 CMS Medicare Program; Inflation Reduction Act (IRA) Medicare Drug Price Negotiation Program Draft Guidance; Comment Request (CMS-4210-N) Rulemaking 2025-12-02T19:19:41Z 0b000064b8d55732 Not Assigned This notice announces an opportunity for the public to comment on CMS' draft guidance for the third cycle of the Medicare Drug Price Negotiation Program, the first cycle of renegotiation, and manufacturer effectuation of the maximum fair price for 2026, 2027, and 2028 for the implementation of the Inflation Reduction Act (IRA).               {"displayProperties": [{"name": "field2", "label": "100 Word Plain Language Summary", "tooltip": "100 Word Plain Language Summary"}], "keywords": null, "modifyDate": "2025-12-02T19:19:41Z", "dkAbstract": "This notice announces an opportunity for the public to comment on CMS' draft guidance for the third cycle of the Medicare Drug Price Negotiation Program, the first cycle of renegotiation, and manufacturer effectuation of the maximum fair price for 2026, 2027, and 2028 for the implementation of the Inflation Reduction Act (IRA).", "agencyId": "CMS", "program": null, "shortTitle": null, "subType2": null, "title": "Medicare Program; Inflation Reduction Act (IRA) Medicare Drug Price Negotiation Program Draft Guidance; Comment Request (CMS-4210-N)", "generic": null, "field1": null, "docketType": "Rulemaking", "petitionNbr": null, "rin": "Not Assigned", "organization": null, "legacyId": null, "subType": null, "category": null, "field2": "This notice announces an opportunity for the public to comment on CMS' draft guidance for the third cycle of the Medicare Drug Price Negotiation Program, the first cycle of renegotiation, and manufacturer effectuation of the maximum fair price for 2026, 20", "effectiveDate": null, "objectId": "0b000064b8d55732"} single_get

Links from other tables